Clinical trial
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
NCT00125307 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- February 29, 2008
- Enrollment
- 20
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.